Yorkville Ives initiates IBM stock coverage with outperform rating
Yorkville Ives initiated coverage on IBM (NYSE:IBM) with an outperform rating and a $275 price target, citing its undervaluation and broad tech capabilities. IBM acquired HRL Labs, plans $10B in quantum computing investments, and trades at a P/E of 19.6 with a 3.05% dividend yield. Q2 2026 earnings missed expectations, leading to a lowered price target from Bernstein SocGen.
How this was made
The 30-second read
Why it matters
The new rating and target could attract fresh buying, offsetting recent earnings disappointment.
Market read
Analyst coverage change provides a fresh catalyst for IBM after a recent earnings miss.
What to watch
Potential execution risk on IBM's quantum investments and competitive pressure in cloud services.
Background
IBM recently reported Q2 2026 results that missed expectations, and Bernstein lowered its target. Yorkville Ives now initiates coverage with a higher target.
Ticker impact
Yorkville Ives initiated coverage on IBM with an outperform rating and a new $275 price target, a fresh analyst action.
likely upward pressure as investors price in the new target
The coverage is new and includes a concrete price target above current levels, prompting buying interest.
Market effects
May boost sentiment for the broader enterprise‑software and cloud hardware sector.
Primarily U.S. market impact; limited regional effect.
Modest, as IBM is a global player but the news is analyst‑specific.
Counterpoint
Some investors may view the target as overly optimistic given recent earnings miss.
Key entities
- AnalystYorkville Ives
Research firm that initiated coverage on IBM.
